All resolutions were adopted
Download the free guide
Boost your gains
The combined shareholders ‘ Meeting of DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – NASDAQ : DBVT), the French biopharmaceutical company, met today at the headquarters of the company 177-181 Avenue Pierre Brossolette in Montrouge (92120), under the chairmanship of Pierre-Henri Benhamou, Chairman and ceo.
The General Assembly approved all of the resolutions proposed by the Board of Directors. These are available on the website of the DBV in the section “Investor Relations” http://www.dbv-technologies.com/fr/relations-investisseurs.
About DBV Technologies
DBV Technologies is developing Viaskin®, a proprietary technology platform with vast fields of potential applications in immunotherapy. Viaskin uses immunotherapy by means epicutaneous, or AVAILABLE on a®, the method developed by DBV for administering biologically active compounds to the immune system through intact skin. With this new category of product candidates non-invasive and self administered, the company strives to transform the care of patients with a food allergy, for which there is no approved treatment. The programs of the DBV related to food allergies include clinical trials of Viaskin Peanut and Viaskin Milk, as well as the clinical development of Viaskin Egg. DBV also achieves a clinical study proof-of-concept in Humans for the treatment of esophagitis eosinophilic and continues to explore the potential applications of its platform in the field of vaccination and other immune diseases.
DBV Technologies has a global headquarters in Montrouge, France and New York, in the United States. The company’s shares are traded on segment A of Euronext Paris (ticker : DBV, ISIN code : FR0010417345), are part of the index SBF 120 and are also traded on the Nasdaq Global Select Market under the form of American Depositary Shares (each representing half of one ordinary share) (ticker : DBVT). For more information on DBV Technologies, please visit our website : www.dbv technologies.com.
Download the free guide
Boost your gains
